Drug profile · INN
esomeprazole
APO-ESOMEPRAZOLE
esomeprazole (APO-ESOMEPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
EMA: approved TGA: approved Alimentary tract and metabolism (A02) A02BC05
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — esomeprazole
- Class
- Alimentary tract and metabolism (A02)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
esomeprazole (APO-ESOMEPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN esomeprazole
Brand APO-ESOMEPRAZOLE
Mechanism Potassium-transporting ATPase inhibitor
Therapeutic class Alimentary tract and metabolism (A02)
ATC code A02BC05
Originator Alphapharm Pty Ltd
Mechanism of action
Potassium-transporting ATPase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is esomeprazole?
esomeprazole (APO-ESOMEPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for esomeprazole?
APO-ESOMEPRAZOLE is a marketed brand name for esomeprazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.